News
CLEW Receives FDA Emergency Use Authorization (EUA) for its Predictive Analytics Platform in Support of COVID-19 Patients
CLEWICU is the only device authorized by the FDA to provide early identification of patients who are likely to experience respiratory failure or hemodynamic instability, both potentially common but significant complications associated with COVID-19
SHAM the Parent Company of the Relyens Mutual Group Forges 5 Exclusive Technology Partnerships
Relyens forges five exclusive technology partnerships to enhance the operational safety of healthcare professionals and local authorities
CLEW Secures Series B Funding
Funding will be used to scale US operations and commercialize CLEW’s critical care platform
Dr. John Halamka Joins CLEW’s Scientific Advisory Board
Prominent healthcare technology pioneer to advise CLEW as the company expands its product offering across the entire continuum of care
CLEW to be featured in a new episode of “Information Matrix”, with Laurence Fishburne
Featuring healthcare industry experts, the program will show how critical care units are using AI-Machine Learning to deliver true patient value
CLEW – Boosting Clinical Analytics with Machine Learning
CLEW used Google Compute Engine to build a reliable, scalable, cloud-based machine learning platform to develop and train its critical care algorithms.
CLEW teams with Mayo Clinic on Critical Care
The study will focus on the feasibility of using the Israeli startup’s analytics platform to predict patient deterioration from infection.
Big Data Co. CLEW and Ichilov to Collaborate
Israeli startup Intensix is developing analytics for early detection of complications or deterioration in intensive care patients.
CLEW – Winner of the Innovation Award
Most Innovative startup at the 22nd annual conference of the Israeli Society for Quality in Healthcare for presenting “The Next Game Changer in Critical Care”
